Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Mammary Gland Biology and Neoplasia
Published in: Journal of Mammary Gland Biology and Neoplasia 3/2019

01-09-2019 | Breast Cancer

The Eleventh ENBDC Workshop: Advances in Technology Help to Unveil Mechanisms of Mammary Gland Development and Cancerogenesis

Authors: Vida Vafaizadeh, Emilia Peuhu, Marja L. Mikkola, Walid T. Khaled, Mohamed Bentires-Alj, Zuzana Koledova

Published in: Journal of Mammary Gland Biology and Neoplasia | Issue 3/2019

Login to get access

Abstract

The eleventh annual workshop of the European Network for Breast Development and Cancer, Methods in mammary gland biology and breast cancer, took place on the 16th to 18th of May 2019 in Weggis, Switzerland. The main topics of the meeting were high resolution genomics and proteomics for the study of mammary gland development and cancer, breast cancer signaling, tumor microenvironment, preclinical models of breast cancer, and tissue morphogenesis. Exciting novel findings in, or highly relevant to, mammary gland biology and breast cancer field were presented, with insights into the methods used to obtain them. Among others, the discussed methods included single-cell RNA sequencing, genetic barcoding, lineage tracing, spatial transcriptomics, optogenetics, genetic mouse models and organoids.
Literature
1.
Pal B, Chen Y, Vaillant F, Jamieson P, Gordon L, Rios AC, et al. Construction of developmental lineage relationships in the mouse mammary gland by single-cell RNA profiling. Nat Commun. 2017;8:1627.CrossRefPubMedPubMedCentral
2.
Merino D, Weber TS, Serrano A, Vaillant F, Liu K, Pal B, et al. Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer. Nat Commun. 2019;10:766.CrossRefPubMedPubMedCentral
3.
Ståhl PL, Salmén F, Vickovic S, Lundmark A, Navarro JF, Magnusson J, et al. Visualization and analysis of gene expression in tissue sections by spatial transcriptomics. Science. 2016;353:78–82.CrossRefPubMed
4.
Salmén F, Vickovic S, Larsson L, Stenbeck L, Vallon-Christersson J, Ehinger A, et al. Multidimensional transcriptomics provides detailed information about immune cell distribution and identity in HER2+ breast tumors. bioRxiv. 2018;358937.
5.
Francavilla C, Rigbolt KTG, Emdal KB, Carraro G, Vernet E, Bekker-Jensen DB, et al. Functional proteomics defines the molecular switch underlying FGF receptor trafficking and cellular outputs. Mol Cell. 2013;51:707–22.CrossRefPubMed
6.
Piasecka D, Kitowska K, Czaplinska D, Mieczkowski K, Mieszkowska M, Turczyk L, et al. Fibroblast growth factor signalling induces loss of progesterone receptor in breast cancer cells. Oncotarget. 2016;7:86011–25.CrossRefPubMedPubMedCentral
7.
Piasecka D, Braun M, Kitowska K, Mieczkowski K, Kordek R, Sadej R, et al. FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors - implications for therapy of luminal breast cancer. J Exp Clin Cancer Res CR. 2019;38:230.CrossRefPubMed
8.
Berto M, Jean V, Zwart W, Picard D. ERα activity depends on interaction and target site corecruitment with phosphorylated CREB1. Life Sci Alliance. 2018;1:e201800055.CrossRefPubMedPubMedCentral
9.
Segala G, Bennesch MA, Ghahhari NM, Pandey DP, Echeverria PC, Karch F, et al. Vps11 and Vps18 of Vps-C membrane traffic complexes are E3 ubiquitin ligases and fine-tune signalling. Nat Commun. 2019;10:1833.CrossRefPubMedPubMedCentral
10.
Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall JF, Harrington K, et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol. 2007;9:1392–400.CrossRefPubMed
11.
Calvo F, Ege N, Grande-Garcia A, Hooper S, Jenkins RP, Chaudhry SI, et al. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat Cell Biol. 2013;15:637–46.CrossRefPubMed
12.
Calvo F, Ranftl R, Hooper S, Farrugia AJ, Moeendarbary E, Bruckbauer A, et al. Cdc42EP3/BORG2 and Septin network enables Mechano-transduction and the emergence of Cancer-associated fibroblasts. Cell Rep. 2015;13:2699–714.CrossRefPubMedPubMedCentral
13.
Duarte AA, Gogola E, Sachs N, Barazas M, Annunziato S, R de Ruiter J, et al. BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance. Nat Methods. 2018;15:134–40.CrossRefPubMed
14.
Gogola E, Duarte AA, de Ruiter JR, Wiegant WW, Schmid JA, de Bruijn R, et al. Selective loss of PARG restores PARylation and counteracts PARP inhibitor-mediated synthetic lethality. Cancer Cell. 2018;33:1078–93 e12.CrossRefPubMed
15.
Noordermeer SM, Adam S, Setiaputra D, Barazas M, Pettitt SJ, Ling AK, et al. The shieldin complex mediates 53BP1-dependent DNA repair. Nature. 2018;560:117–21.CrossRefPubMedPubMedCentral
16.
Barazas M, Gasparini A, Huang Y, Küçükosmanoğlu A, Annunziato S, Bouwman P, et al. Radiosensitivity is an acquired vulnerability of PARPi-resistant BRCA1-deficient tumors. Cancer Res. 2019;79:452–60.CrossRefPubMed
17.
Acerbi I, Cassereau L, Dean I, Shi Q, Au A, Park C, et al. Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. Integr Biol Quant Biosci Nano Macro. 2015;7:1120–34.
18.
Mohammadi H, Sahai E. Mechanisms and impact of altered tumour mechanics. Nat Cell Biol. 2018;20:766–74.CrossRefPubMed
19.
Mayorca-Guiliani AE, Madsen CD, Cox TR, Horton ER, Venning FA, Erler JT. ISDoT: in situ decellularization of tissues for high-resolution imaging and proteomic analysis of native extracellular matrix. Nat Med. 2017;23:890–8.CrossRefPubMed
20.
21.
Simões BM, O’Brien CS, Eyre R, Silva A, Yu L, Sarmiento-Castro A, et al. Anti-estrogen resistance in human breast tumors is driven by JAG1-NOTCH4-dependent Cancer stem cell activity. Cell Rep. 2015;12:1968–77.CrossRefPubMedPubMedCentral
22.
Zhao Y, Hu Q, Cheng F, Su N, Wang A, Zou Y, et al. SoNar, a highly responsive NAD+/NADH sensor, allows high-throughput metabolic screening of anti-tumor agents. Cell Metab. 2015;21:777–89.CrossRefPubMedPubMedCentral
23.
24.
Pearl EJ, Li J, Green JBA. Cellular systems for epithelial invagination. Philos Trans R Soc B Biol Sci. 2017;372:20150526.CrossRef
25.
Li J, Economou AD, Green JBA. Epithelial invagination by vertical telescoping. bioRxiv. 2019;515981.
26.
Izquierdo E, Quinkler T, De Renzis S. Guided morphogenesis through optogenetic activation of rho signalling during early Drosophila embryogenesis. Nat Commun. 2018;9:2366.CrossRefPubMedPubMedCentral
27.
Krueger D, Tardivo P, Nguyen C, De Renzis S. Downregulation of basal myosin-II is required for cell shape changes and tissue invagination. EMBO J. 2018;37.
28.
Wuidart A, Ousset M, Rulands S, Simons BD, Van Keymeulen A, Blanpain C. Quantitative lineage tracing strategies to resolve multipotency in tissue-specific stem cells. Genes Dev. 2016;30:1261–77.CrossRefPubMedPubMedCentral
29.
Wuidart A, Sifrim A, Fioramonti M, Matsumura S, Brisebarre A, Brown D, et al. Early lineage segregation of multipotent embryonic mammary gland progenitors. Nat Cell Biol. 2018;20:666–76.CrossRefPubMedPubMedCentral
30.
Santoro A, Vlachou T, Carminati M, Pelicci PG, Mapelli M. Molecular mechanisms of asymmetric divisions in mammary stem cells. EMBO Rep. 2016;17:1700–20.CrossRefPubMedPubMedCentral
31.
Myllymäki S-M, Mikkola ML. Inductive signals in branching morphogenesis - lessons from mammary and salivary glands. Curr Opin Cell Biol. 2019;61:72–8.CrossRefPubMed
32.
Lloyd-Lewis B, Mourikis P, Fre S. Notch signalling: sensor and instructor of the microenvironment to coordinate cell fate and organ morphogenesis. Curr Opin Cell Biol. 2019;61:16–23.CrossRefPubMed
33.
Koledova Z, Sumbal J. A pleiotropic role for FGF signaling in mammary gland stromal fibroblasts. bioRxiv. 2019;565267.
34.
Lerche M, Elosegui-Artola A, Guzmán C, Georgiadou M, Kechagia JZ, Gullberg D, et al. Integrin binding dynamics modulate ligand-specific mechanosensing in mammary gland fibroblasts. bioRxiv. 2019;570721.
35.
Marusiak AA, Prelowska MK, Mehlich D, Lazniewski M, Kaminska K, Gorczynski A, et al. Upregulation of MLK4 promotes migratory and invasive potential of breast cancer cells. Oncogene. 2019;38:2860–75.CrossRefPubMed
36.
Koledova Z, Howard BA, Englund J, Bach K, Bentires-Alj M, Gonzalez-Suarez E. European network of breast development and Cancer turned 10 years: a growing family of mammary gland researchers. Breast Cancer Res BCR. 2018;20:102.CrossRefPubMed
Metadata
Title
The Eleventh ENBDC Workshop: Advances in Technology Help to Unveil Mechanisms of Mammary Gland Development and Cancerogenesis
Authors
Vida Vafaizadeh
Emilia Peuhu
Marja L. Mikkola
Walid T. Khaled
Mohamed Bentires-Alj
Zuzana Koledova
Publication date
01-09-2019
Publisher
Springer US
Published in
Journal of Mammary Gland Biology and Neoplasia / Issue 3/2019
Print ISSN: 1083-3021
Electronic ISSN: 1573-7039
DOI
https://doi.org/10.1007/s10911-019-09436-0

Other articles of this Issue 3/2019

Journal of Mammary Gland Biology and Neoplasia 3/2019 Go to the issue

OriginalPaper

GATA3 Truncating Mutations Promote Cistromic Re-Programming In Vitro, but Not Mammary Tumor Formation in Mice

ReviewPaper

Emerging Role of SOX Proteins in Breast Cancer Development and Maintenance

OriginalPaper

The Milk Protein Alpha-Casein Suppresses Triple Negative Breast Cancer Stem Cell Activity Via STAT and HIF-1alpha Signalling Pathways in Breast Cancer Cells and Fibroblasts

ReviewPaper

How to Choose a Mouse Model of Breast Cancer, a Genomic Perspective

ReviewPaper

Remodeling of Murine Mammary Adipose Tissue during Pregnancy, Lactation, and Involution

OriginalPaper

BRCA1 Attenuates Progesterone Effects on Proliferation and NFκB Activation in Normal Human Mammary Epithelial Cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits